Business Wire

Corsearch Announces Strategic Partnerships with Key-Systems GmbH and INCOPRO

Share

Corsearch, a premier provider of clearance and protection solutions for trademark and brand professionals, is pleased to announce strategic partnerships with Key-Systems, a global player in the internet and domain industry, and INCOPRO, a leading online IP and brand protection company. The agreements solidify Corsearch’s full service domain management and brand protection offerings for law firms .

“We are thrilled to be moving forward in a new partnership with Key Systems to complement our existing partnership with COM LAUDE, and to be expanding the partnership we have with INCOPRO,” said Corsearch President and CEO Tobi Hartmann. “These relationships will allow Corsearch to expand its domain name management and brand protection solutions for law firms and their end clients.”

Corsearch & Key-Systems Partnership

Working with the corporate domain management solution “BrandShelter", Corsearch will provide law firms an easy way to manage the domain portfolios of their clients. This collaboration will provide law firms powerful and stable domain management through one of the largest registrars in Europe.

“We are excited to have won Corsearch as a partner,” said Alexander Siffrin, Key-Systems CEO. “Our customers will benefit from our joint expertise and excellence.”

In addition to the fully automated and white labeled interface, this cooperation allows Corsearch and Key-Systems to provide a dedicated account management team of industry experts, automatic renewal of all domains in management, and a completely automated and customizable billing system which is able to send invoices in the law firm’s name with the given pricing for their clients.

Corsearch & INCOPRO Partnership

Corsearch & INCOPRO today announce a renewal of their collaboration aimed at enabling law firms to deliver strategic advice and online enforcement for their clients. Corsearch will offer a law firm edition of INCOPRO’s innovative brand protection technology, providing law firms with the technology to defend their clients’ intellectual property from online abuse.

“As a lawyer myself, I know that technology has a huge role to play in enabling law firms to deliver strategic and cost-effective advice and support to clients,” said INCOPRO CEO Simon Baggs. “INCOPRO is thrilled to be working with Corsearch in delivering this new and exciting solution.”

Online IP infringement is a rapidly growing challenge for all brands as e-commerce expands and digital becomes the core business strategy. Using the Corsearch INCOPRO platform, law firms can efficiently identify the strategic challenges affecting their clients’ brands, adding to the value they offer their clients and strengthening their IP services.

Corsearch will be the exclusive provider of this law firm edition of the INCOPRO system, offering a market-leading proposition to its law firm clients. Corsearch & INCOPRO first partnered in 2016 and this new proposition reinforces the strength of the partnership.

About Corsearch

Corsearch is a premier provider of clearance and protection solutions for trademark and brand professionals. Its high-quality, intuitive tools and unparalleled expertise enable professionals to effectively manage their trademark screening, search review, watching, and domain management processes. With highly trained researchers, an expansive global content set and customer-focused technology tools available through the Corsearch platform, Corsearch empowers its customers with powerful brand solutions in an increasingly complex business environment.

For more information visit Corsearch.com.

About Key-Systems

Founded in 1998, Key-Systems is a global player of the internet and domain industry. Its core business is the registration of internet addresses – Key-Systems currently manages more than 5 million domains on behalf of its customers.

Besides domain registrations, Key-Systems' three differently targeted business divisions and the two wholly owned subsidiaries offer comprehensive IT services. These include the operation of a registry, colocation, virtual servers, web hosting, SSL certificates and brand monitoring on the Internet.

Key-Systems serves customers all over the world, among them are private clients, mid-sized businesses, well-known domain investors as well as large international organizations and corporations. With diversified offerings, trusted technique, and our experienced team of more than 100 domain experts Key-Systems expanded its customer base to more than 100,000 retail/corporate customers and over 2,300 resellers worldwide. For more information regarding Key-Systems GmbH, visit www.key-systems.net.

About INCOPRO

Founded in 2011, INCOPRO is an online IP and brand protection company. Its proprietary technology platform TALISMAN collates data on brand infringement and automatically identifies and prioritizes IP violations. Its clustering technology is uniquely able to track and connect the commercial scale counterfeiters, enabling comprehensive takedown of all associated operations. Headquartered in London, with INCOPRO’s analysts working across the United States, Europe, and Asia, INCOPRO works with some of the largest global brands to provide connected and actionable insights into IP infringements online. For additional information regarding INCOPRO, please visit www.incoproip.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Corsearch
Brett Amdur, 800-732-7241
Chief Marketing and Strategy Officer

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

HiddenA line styled icon from Orion Icon Library.Eye